Sponsors Rein In Clinical Trial Violation Rate, But Monitoring Is Problematic

Despite improvements in sponsors' compliance with clinical trial regulations last year, trial monitoring continues to be an issue, according to CDRH

More from Archive

More from Medtech Insight